Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors
Abstract
Angioedema is a rare, potentially life-threatening adverse event of renin-angiotensin system inhibitors. The objective of the present study was to determine the risk of angioedema from randomized clinical trials. A PubMed/CENTRAL/EMBASE search was made for randomized clinical trials from 1980 to October 2011 in patients on angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), or direct renin inhibitor (DRI). Trials with a total number of patients ≥100 and a duration of ≥8 weeks were included for analysis. Incidence of angioedema was pooled by weighing the incident rate of each trial by the inverse of the variance. Twenty-six trials with 74,857 patients in the ACE inhibitor arm with 232,523 person-years of follow-up, 19 trials with 35,479 patients on ARB with 122,293 person-years of follow-up, and 2 trials with 5,141 patients on DRI with 1,735 person-years of follow-up met the inclusion criteria and were included in the analysis. In head-to-head comparison in 7 trials, risk of angioedema with ACE inhibitors was 2.2 times higher than with ARBs (95% confidence interval [CI] 1.5 to 3.3). With ACE inhibitors and ARBs, incidence of angioedema was higher in heart failure trials compared to hypertension or coronary artery disease trials without heart failure (p <0.0001). Weighted incidence of angioedema with ACE inhibitors was 0.30% (95% CI 0.28 to 0.32) compared to 0.11% (95% CI 0.09 to 0.13) with ARBs, 0.13% (95% CI 0.08 to 0.19) with DRIs, and 0.07%…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Angioedema has been associated with the use of ACEi, with a weighted incidence of 0.30% (95% CI: 0.28-0.32) reported in 1 systematic review.
“However, angioedema has been associated with the use of ACEi, with a weighted incidence of 0.30% (95% CI: 0.28 -0.32) reported in 1 systematic review.”
From KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (2022) · cites this paper as [54]
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823 · see citing works
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · see citing works
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859 · see citing works
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663 · see citing works
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987 · see citing works
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664 · see citing works
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407 · see citing works
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826 · see citing works
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502 · see citing works
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396 · see citing works
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203 · see citing works
McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604 · see citing works
Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J.-L., Køber, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032292 · Cited by 2,471 · see citing works
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
Jamerson, K., Weber, M. A., Bakris, G. L., Dahlöf, B., Pitt, B., Shi, V., Hester, A., Gupte, J., Gatlin, M., & Velazquez, E. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806182 · Cited by 2,065 · see citing works
Wright, J. T. (2002) · JAMA · doi:10.1001/jama.288.19.2421 · Cited by 2,033 · see citing works
Granger, C. B., McMurray, J. J., Yusuf, S., Held, P., Michelson, E. L., Olofsson, B., Östergren, J., Pfeffer, M. A., & Swedberg, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14284-5 · Cited by 1,686 · see citing works
Pitt, B., Segal, R., Martínez, F. A., Meurers, G., Cowley, A. J., Thomas, I., DEEDWANIA, P. C., Ney, D. E., Snavely, D. B., & Chang, P. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01187-2 · Cited by 1,656 · see citing works
The perindopril in elderly people with chronic heart failure (PEP-CHF) study
Cleland, J. G. F. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl250 · Cited by 1,502 · see citing works
Dickstein, K., & KJEKSHUS, J. K. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09895-1 · Cited by 1,200 · see citing works
Angiotensin-converting-enzyme inhibition in stable coronary artery disease
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa042739 · Cited by 1,123 · see citing works
McMurray, J. J. V., Östergren, J., Swedberg, K. B., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer (2003) · The Lancet · Cited by 1,043 · see citing works
Preventing Microalbuminuria in Type 2 Diabetes
Ruggenenti, P. L., Fassi, A., Parvanova, A. I., Bruno, S., Iliev, I. P., Brusegan, V., Rubis, N., Gherardi, G., Arnoldi, F., Ganeva, M. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042167 · Cited by 1,012 · see citing works
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Bradburn, M. J., Deeks, J. J., Berlin, J. A., & Russell Localio, A. (2007) · Statistics in Medicine · doi:10.1002/sim.2528 · Cited by 938 · see citing works
Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker
Julius, S., Nesbitt, S. D., Egan, B. M., Weber, M. A., Michelson, E. L., Kaciroti, N., Black, H. R., Grimm, R. H., Messerli, F. H., Oparil, S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060838 · Cited by 919 · see citing works
Self-citationIsraili, Z. H., & Hall, W. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-234 · Cited by 910 · see citing works
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792 · see citing works
Konstam, M. A., Neaton, J. D., Dickstein, K., Drexler, H., Komajda, M., Martinez, F. A., Riegger, G. A., Malbecq, W., Smith, R. D., Guptha, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61913-9 · Cited by 646 · see citing works
Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure
Packer, M., Califf, R. M., Konstam, M. A., Krum, H., McMurray, J. J. V., Rouleau, J. L., & Swedberg, K. B. (2002) · Circulation · doi:10.1161/01.cir.0000029801.86489.50 · Cited by 615 · see citing works
Chaturvedi, N., Porta, M., Klein, R., Orchard, T. J., Fuller, J., Parving, H. H., Bilous, R., & Sjølie, A. K. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61412-9 · Cited by 450 · see citing works
Clinical Profile of Angioedema Associated With Angiotensin Converting-Enzyme Inhibition
Slater, E. E. (1988) · JAMA · doi:10.1001/jama.1988.03410070095035 · Cited by 368 · see citing works
Metabolic outcome during 1 year in newly detected hypertensives
Lindholm, L. H., Persson, M., Alaupovic, P., Carlberg, B., Svensson, A., & Samuelsson, O. G. (2003) · Journal of Hypertension · doi:10.1097/00004872-200308000-00022 · Cited by 353 · see citing works
Brown, N. J., Ray, W. A., Snowden, M., & Griffin, M. R. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90161-7 · Cited by 313 · see citing works
Lindholm, L. H., Persson, M., Alaupovic, P., Carlberg, B., Svensson, A., & Samuelsson, O. G. (2003) · PubMed · doi:10.1097/01.hjh.0000084723.53355.76 · Cited by 308 · see citing works
Marre, M., Lièvre, M. M., Châtellier, G., Mann, J. F. E., Passa, P., & Ménard, J. (2004) · BMJ · doi:10.1136/bmj.37970.629537.0d · Cited by 291 · see citing works
Incidence and Characteristics of Angioedema Associated With Enalapril
Kostis, J. B., Kim, H. J., Rusnak, J., Casale, T., Kaplan, A., Corren, J., & Levy, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.14.1637 · Cited by 291 · see citing works
Bradykinin-Mediated Angioedema
Nussberger, J., Cugno, M., & Cicardi, M. (2002) · New England Journal of Medicine · doi:10.1056/nejm200208223470820 · Cited by 232 · see citing works
Nonallergic angioedema: role of bradykinin
Baş, M., Adams, V., Suvorava, T., Niehues, T., Hoffmann, T. K., & Kojda, G. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01427.x · Cited by 231 · see citing works
Vasopeptidase inhibition and angio-oedema
Messerli, F. H., & Nussberger, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02596-4 · Cited by 222 · see citing works
Self-citationAngioedema without urticaria: a large clinical survey
Zingale, L. C., Beltrami, L., Zanichelli, A., Maggioni, L., Pappalardo, E. M., Cicardi, B., & Cicardi, M. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060535 · Cited by 217 · see citing works
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (2000) · Revista Española de Salud Pública · doi:10.1590/s1135-57272000000200002 · Cited by 213 · see citing works
Losartan Increases Bradykinin Levels in Hypertensive Humans
Campbell, D. J., Krum, H., & Esler, M. (2005) · Circulation · doi:10.1161/01.cir.0000153269.07762.3b · Cited by 183 · see citing works
Brown, M. J., McInnes, G. T., Papst, C. C., Zhang, J. Y., & MacDonald, T. M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62003-x · Cited by 166 · see citing works
Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD)
Kostis, J. B., Shelton, B. J., Gosselin, G., Goulet, C., Hood, W. B., Kohn, R. M., Kubo, S. H., SCHRON, E. B., Weiss, M. B., Willis, P. W., et al. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90365-8 · Cited by 156 · see citing works
Zanchetti, A., Crepaldi, G., Bond, M. G., Gallus, G., Veglia, F., Mancia, G., Ventura, A., Baggio, G., Sampieri, L., Rubba, P., et al. (2004) · Stroke · doi:10.1161/01.str.0000147041.00840.59 · Cited by 154 · see citing works
Angioedema due to angiotensin-converting enzyme inhibitors
Agostoni, A., Cicardi, M., Cugno, M., Zingale, L. C., Gioffré, D., & Nussberger, J. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00107-1 · Cited by 147 · see citing works
The PREAMI Investigators* (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.6.659 · Cited by 138 · see citing works
McGill, J. B., & Reilly, P. A. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80072-2 · Cited by 118 · see citing works
Karlberg, B. E., Lins, L., & Hermansson, K. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00015 · Cited by 97 · see citing works
Increased sensitivity to bradykinin among African Americans
Gainer, J. V., Nadeau, J. H., Ryder, D., & Brown, N. J. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70151-3 · Cited by 89 · see citing works
Comparison of Telmisartan with Lisinopril in Patients with Mild-to-Moderate Hypertension
Neutel, J. M., Frishman, W. H., Oparil, S., Papademitriou, V., & Guthrie, G. (1999) · American Journal of Therapeutics · doi:10.1097/00045391-199905000-00007 · Cited by 77 · see citing works
Beavers, C. J., Dunn, S. P., & Macaulay, T. E. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p630 · Cited by 72 · see citing works
Landmark Publication from The American Journal of the Medical Sciences
Osler, W. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181b2803f · Cited by 55 · see citing works
White, W. B., Bresalier, R. S., Kaplan, A. P., Palmer, B. F., Riddell, R. H., Lesogor, A., Chang, W., & Keefe, D. L. (2010) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00352.x · Cited by 54 · see citing works
Angiotensin-Converting Enzyme Inhibitors and Angioedema
Weber, M. A., & Messerli, F. H. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.111393 · Cited by 52 · see citing works
Self-citationEffects of angiotensin-converting enzyme inhibition on transient ischemia
Pepine, C. J., Rouleau, J. L., Annis, K., Ducharme, A., Ma, P. T. S., Lenis, J., Davies, R., Thadani, U., CHAITMAN, B. R., Haber, H. E., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.027 · Cited by 47 · see citing works
Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers
Cesari, M., Kritchevsky, S. B., Atkinson, H. H., Penninx, B. W. J. H., Bari, M. D., Tracy, R. P., & Pahor, M. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.10.026 · Cited by 36 · see citing works
Baguet, J.-P. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3409 · Cited by 33 · see citing works
Himmelmänn, A., Keinanen-Kiukaanniemi, S. M., Wester, A., Redón, J., Asmar, R. G., & Hedner, T. (2001) · Blood Pressure · doi:10.1080/080370501750183381 · Cited by 26 · see citing works
Volpe, M., Junren, Z., Maxwell, T., Rodríguez, A., Gamboa, R., Gómez-Fernández, P., Ortega-Gonzalez, G., Matadamas, N., Rodríguez, F., Dass, B., et al. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80133-9 · Cited by 25 · see citing works
Haymore, B. R., & DeZee, K. J. (2009) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60151-2 · Cited by 18 · see citing works
Cugno, M., Agostoni, P., Mari, D., Meroni, P. L., Gregorini, L., Bussotti, M., Anguissola, G. B., Donatelli, F., & Nussberger, J. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05569.x · Cited by 17 · see citing works
Maclean, D., Ramsay, L., & Richardson, P. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03766.x · Cited by 12 · see citing works
The long-term tolerability of enalapril in hypertensive patients with renal impairment.
Keane, W. F., Polis, A., Wolf, D., Faison, E. P., & Shahinfar, S. (1997) · PubMed · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536 · see citing works
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862 · see citing works
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922 · see citing works
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,129 · see citing works
KDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease
de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.019 · Cited by 1,399 · see citing works
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.008 · Cited by 1,373 · see citing works
Cicardi, M., Aberer, W., Banerji, A., Baş, M., Bernstein, J. A., Bork, K., Caballero, T., Farkas, H., Grumach, A. S., Kaplan, A. P., et al. (2014) · Allergy · doi:10.1111/all.12380 · Cited by 659 · see citing works
Propensity Score Methods for Confounding Control in Nonexperimental Research
Brookhart, M. A., Wyss, R., Layton, J. B., & Stürmer, T. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000359 · Cited by 590 · see citing works
Angiotensin-Converting Enzyme Inhibitors in Hypertension
Messerli, F. H., Bangalore, S., Bavishi, C., & Rimoldi, S. F. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.01.058 · Cited by 359 · see citing works
Self-citationChiang, C., Wang, T., Ueng, K.-C., Lin, T., Yeh, H., Chen, C.-Y., Wu, Y.-J., Tsai, W., Chao, T., Chen, C.-H., et al. (2014) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2014.11.005 · Cited by 201 · see citing works
Aygören-Pürsün, E., Magerl, M., Maetzel, A., & Maurer, M. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0815-5 · Cited by 169 · see citing works
Angioedema Due to Bradykinin Dysregulation
Cicardi, M., & Zuraw, B. L. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.04.022 · Cited by 149 · see citing works
ACE Inhibitor-Induced Angioedema: a Review
Kostis, W. J., Shetty, M., Chowdhury, Y. S., & Kostis, J. B. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0859-x · Cited by 145 · see citing works
Angiotensin‐converting enzyme inhibitor–induced angioedema: A review of the literature
Brown, T. V., Gonzalez, J., & Monteleone, C. A. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13097 · Cited by 125 · see citing works
Epidemiology of ACE Inhibitor Angioedema Utilizing a Large Electronic Health Record
Banerji, A., Blumenthal, K. G., Lai, K. H., & Zhou, L. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.02.018 · Cited by 114 · see citing works
Bavishi, C., Messerli, F. H., KADOSH, B. S., Ruilope, L. M., & Kario, K. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv142 · Cited by 108 · see citing works
Self-citationAngiotensin-converting Enzyme Inhibitor-induced Angioedema
Bezalel, S. R., Mahlab‐Guri, K., Asher, I., Werner, B., & Sthoeger, Z. M. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.07.011 · Cited by 103 · see citing works
Angioedema Phenotypes: Disease Expression and Classification
Wu, M. A., Perego, F., Zanichelli, A., & Cicardi, M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8541-z · Cited by 96 · see citing works
Evaluation and Management of Angioedema in the Emergency Department
Long, B., Koyfman, A., & Gottlieb, M. A. (2019) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2019.5.42650 · Cited by 81 · see citing works
Renin–Angiotensin System Blocking Drugs
Robles, N. R., Cerezo, I., & Hernández‐Gallego, R. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413501018 · Cited by 72 · see citing works
Cheung, D. G., Aizenberg, D., Gorbunov, V. M., Hafeez, K., Chen, C., & Zhang, J. Y. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13153 · Cited by 71 · see citing works
Takuathung, M. N., Sakuludomkan, W., Khatsri, R., Dukaew, N., Kraivisitkul, N., Ahmadmusa, B., Mahakkanukrauh, C., Wangthaweesap, K., Onin, J., Srichai, S., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19148373 · Cited by 71 · see citing works
Heidenreich, P. A., Solis, P., Estes, N. A. M., Fonarow, G. C., Jurgens, C. Y., Marine, J. E., McManus, D. D., & McNamara, R. L. (2016) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000018 · Cited by 62 · see citing works
Heidenreich, P. A., Solis, P., Estes, N. A. M., Fonarow, G. C., Jurgens, C. Y., Marine, J. E., McManus, D. D., & McNamara, R. L. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.521 · Cited by 58 · see citing works
Nosbaum, A., Bouillet, L., Floccard, B., Javaud, N., Launay, D., Boccon‐Gibod, I., & Fain, O. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.12.017 · Cited by 55 · see citing works
CT Findings of Acute Small-Bowel Entities
Sugi, M. D., Menias, C. O., Lubner, M. G., Bhalla, S., Mellnick, V. M., Kwon, M. H., & Katz, D. S. (2018) · Radiographics · doi:10.1148/rg.2018170148 · Cited by 54 · see citing works
The Mechanism of Action of LCZ696
Menéndez, J. L. T. (2016) · Cardiac failure review · doi:10.15420/cfr.2016:1:1 · Cited by 55 · see citing works
Vascular (dys)function in the failing heart
Liberale, L., Duncker, D. J., Hausenloy, D. J., Kraler, S. C., Bøtker, H. E., Podesser, B. K., Heusch, G., & Kleinbongard, P. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01163-w · Cited by 55 · see citing works
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension?
Turner, J. M., & Kodali, R. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01352-8 · Cited by 54 · see citing works
Sacubitril/Valsartan (LCZ696) in Heart Failure
Khder, Y., Shi, V. C., McMurray, J. J. V., & Lefkowitz, M. P. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_77 · Cited by 47 · see citing works
Critical insights into the beneficial and protective actions of the kallikrein–kinin system
Regoli, D. C., & Gobeil, F. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2014.12.003 · Cited by 46 · see citing works
Cicardi, M., Bellis, P., Bertazzoni, G., Cancian, M., Chiesa, M., Cremonesi, P., Marino, P., Montano, N., Morselli, C., Ottaviani, F., et al. (2013) · Internal and Emergency Medicine · doi:10.1007/s11739-013-0993-z · Cited by 46 · see citing works
Current pharmacotherapy of bradykinin-mediated angioedema
Farkas, H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.778826 · Cited by 45 · see citing works
Bradykinin Metabolism and Drug-Induced Angioedema
Smolińska, S., Antolín‐Amérigo, D., & Popescu, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411649 · Cited by 41 · see citing works
Angioedema in the emergency department: an evidence-based review.
Wilkerson, R. G. (2012) · PubMed · Cited by 41 · see citing works
Myakala, K., Jones, B. A., Wang, X. X., & Levi, M. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00614.2020 · Cited by 41 · see citing works
Mahmoudpour, S. H., Baranova, E. V., Souverein, P. C., Asselbergs, F. W., de Boer, A., Maitland‐van der Zee, A. H., & on behalf of the PREDICTION‐ADR consortium (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13090 · Cited by 40 · see citing works
Shi, V. C., Senni, M., Streefkerk, H. J., Modgill, V., Zhou, W., & Kaplan, A. P. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.121 · Cited by 40 · see citing works
Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics
Marcelino-Rodríguez, I., Callero, A., Mendoza-Álvarez, A., Perez-Rodriguez, E., Barrios-Recio, J., García-Robaina, J. C., & Flores, C. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00900 · Cited by 40 · see citing works
Treatment of ACEI-related angioedema with icatibant: a case series
Bova, M., Guilarte, M., Sala-Cunill, A., Borrelli, P., Rizzelli, G. M. L., & Zanichelli, A. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1205-9 · Cited by 39 · see citing works
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)
Leong, D. P., McMurray, J. J. V., Joseph, P. G., & Yusuf, S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.068 · Cited by 39 · see citing works
Alharbi, F., Kholod, A. A. V., Souverein, P. C., Meyboom, R. H. B., de Groot, M., de Boer, A., & Klungel, O. H. (2017) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12313 · Cited by 36 · see citing works
State-of-the-art treatment of hypertension: established and new drugs
Burnier, M., Vuignier, Y., & Wuerzner, G. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht465 · Cited by 35 · see citing works
Reza, H. M., Tabassum, N., Sagor, M. A. T., Chowdhury, M. R. H., Rahman, M., Jain, P., & Alam, M. A. (2016) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2015.1124956 · Cited by 33 · see citing works
Predictors of Airway Intervention in Angiotensin‐Converting Enzyme Inhibitor–Induced Angioedema
Kieu, M. C. Q., Bangiyev, J. N., Thottam, P. J., & Levy, P. D. (2015) · Otolaryngology · doi:10.1177/0194599815588909 · Cited by 32 · see citing works
Hahn, J., Hoffmann, T. K., Bock, B., Nordmann-Kleiner, M., Trainotti, S., & Greve, J. (2017) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2017.0489 · Cited by 32 · see citing works
Sharp, S., Poglitsch, M., Zilla, P., Davies, N. H., & Sturrock, E. D. (2015) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320314568438 · Cited by 31 · see citing works
Cardiovascular and Diabetic Medications That Cause Bradykinin-Mediated Angioedema
Hudey, S. N., Westermann-Clark, E., & Lockey, R. F. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.03.017 · Cited by 31 · see citing works
ACE Inhibitor-Induced Angioedema of the Small Bowel: A Case Report and Review of the Literature
Wilin, K., Czupryn, M. J., Mui, R., Renno, A. W., & Murphy, J. A. (2017) · Journal of Pharmacy Practice · doi:10.1177/0897190017690641 · Cited by 30 · see citing works
Junior, P. F. G.-B., Arruda, L. K., Aun, M. V., Campos, R. A., Chong‐Neto, H. J., Constantino-Silva, R. N., Fernandes, F. R., Ferraro, M. F., Ferriani, M. P. L., França, A. T., et al. (2018) · Clinics · doi:10.6061/clinics/2018/e310 · Cited by 30 · see citing works
Faisant, C., Armengol, G., Bouillet, L., Boccon‐Gibod, I., Villier, C., Levesque, H., Cottin, J., Massy, N., & Benhamou, Y. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0228-3 · Cited by 29 · see citing works
Lipski, S. M., Casimir, G. J., Vanlommel, M., Jeanmaire, M., & Dolhen, P. (2014) · Clinical Case Reports · doi:10.1002/ccr3.171 · Cited by 26 · see citing works
Ramipril-Induced Liver Injury: Case Report and Review of the Literature
Douros, A., Kauffmann, W., Bronder, E., Klimpel, A., Garbe, E., & Kreutz, R. H. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt090 · Cited by 26 · see citing works
Stauber, T., Confino‐Cohen, R., & Goldberg, A. (2014) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2014.28.3989 · Cited by 25 · see citing works
Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
Gelfand, J. M., Song, W. B., Langan, S., & Garshick, M. S. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01097-9 · Cited by 23 · see citing works
What’s New in the Treatment of Urticaria and Angioedema
Khan, D. A., Kocatürk, E., Bauer, A., & Aygören‐Pürsün, E. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.03.012 · Cited by 24 · see citing works
Gang, C., Lindsell, C. J., Moellman, J. J., Sublett, W., Hart, K., Collins, S. P., & Bernstein, J. A. (2013) · Allergy and Asthma Proceedings · doi:10.2500/aap.2013.34.3664 · Cited by 23 · see citing works
Management of angioedema without urticaria in the emergency department
Pedrosa, M., Prieto, A., Sala-Cunill, A., on Behalf of the Spanish Group for the Study of Bradykinin-Mediated Angioedema (SGBA) and the Spanish Committee of Cutaneous Allergy (CCA), Members of the Spanish Group for the Study of Bradykinin-Mediated Angioedema (SGBA):, Caballero, T., Baeza, M. L., Cabañas, R., Campos, A., Cimbollek, S., et al. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.949300 · Cited by 23 · see citing works
Pharmacogenetics of angiotensin‐converting enzyme inhibitor‐induced angioedema
Liau, Y., Chua, I. C., Kennedy, M. A., & Maggo, S. D. S. (2018) · Clinical & Experimental Allergy · doi:10.1111/cea.13326 · Cited by 23 · see citing works
Bindke, G., Gehring, M., Wieczorek, D., Kapp, A., Buhl, T., & Wedi, B. (2021) · Allergy · doi:10.1111/all.15013 · Cited by 21 · see citing works
Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema
Wilkerson, R. G., & Winters, M. E. (2021) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2021.09.004 · Cited by 21 · see citing works
Angioedema associated with dipeptidyl peptidase-IV inhibitors
Cassano, N., Nettis, E., Leo, E. D., Ambrogio, F., Vena, G. A., & Foti, C. (2021) · Clinical and Molecular Allergy · doi:10.1186/s12948-021-00164-7 · Cited by 21 · see citing works
Why Are We Still Prescribing Angiotensin-Converting Enzyme Inhibitors?
Messerli, F. H., Bavishi, C., & Bangalore, S. (2022) · Circulation · doi:10.1161/circulationaha.121.057835 · Cited by 21 · see citing works
Self-citationAngioedema Related to Angiotensin Inhibitors
Knecht, S. E., Dunn, S. P., & Macaulay, T. E. (2014) · Journal of Pharmacy Practice · doi:10.1177/0897190014546101 · Cited by 19 · see citing works
Do, T. P., Seetasith, A., Belleli, R., Schlienger, R. G., Corda, S., Burudpakdee, C., Streefkerk, H. J., & Behr, S. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0256-x · Cited by 19 · see citing works
Cutaneous effects of antihypertensive drugs
Baccino, D., Merlo, G., Cozzani, E., Rosa, G. M., Tini, G., Burlando, M., & Parodi, A. (2020) · Giornale Italiano di Dermatologia e Venereologia · doi:10.23736/s0392-0488.19.06360-0 · Cited by 19 · see citing works
Update on bradykinin-mediated angioedema in 2020
Lepelley, M., Bernardeau, C., Defendi, F., Crochet, J., Mallaret, M., & Bouillet, L. (2020) · Therapies · doi:10.1016/j.therap.2020.02.011 · Cited by 19 · see citing works
Pharmacokinetic evaluation of lisinopril-tryptophan, a novel C-domain ACE inhibitor
Denti, P., Sharp, S.-K., Kröger, W. L., Schwager, S. L. U., Mahajan, A., Njoroge, M., Gibhard, L., Smit, I., Chibale, K., Wiesner, L., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.01.012 · Cited by 18 · see citing works
Leru, P. M., Anton, V. F., Bocșan, I. C., Muntean, A. M., & Boda, D. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8474 · Cited by 18 · see citing works
Dubrall, D., Schmid, M. C., Stingl, J., & Sachs, B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230632 · Cited by 18 · see citing works
Pharmacologic management of angioedema induced by angiotensin-converting enzyme inhibitors
Scalese, M. J., & Reinaker, T. S. (2016) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150482 · Cited by 16 · see citing works
Chrysant, S. G. (2017) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2017.04.012 · Cited by 16 · see citing works
Bradykinin-Mediated Angioedema Induced by Drugs
Suffritti, C., Chan, S., Ferrara, A. L., Lekli, E., Palestra, F., Tuncay, G., Loffredo, S., & Bova, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14165712 · Cited by 15 · see citing works
Drug-induced angioedema: experience of Italian emergency departments
Bertazzoni, G., Spina, M. T., Scarpellini, M. G., Buccelletti, F., Simone, M. D., Gregori, M., Valeriano, V., Pugliese, F., Ruggieri, M., Magnanti, M., et al. (2013) · Internal and Emergency Medicine · doi:10.1007/s11739-013-1007-x · Cited by 15 · see citing works
Lochbaum, R., Hoffmann, T. K., Greve, J., & Hahn, J. (2023) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.15154 · Cited by 14 · see citing works
Fatal outcome of late-onset angiotensin-converting enzyme inhibitor induced angioedema
Jackevičiūtė, J., Pilvinis, V., & Pilvinienė, R. (2018) · Medicine · doi:10.1097/md.0000000000011695 · Cited by 14 · see citing works
Dani, S. S., Ganatra, S., & Vaduganathan, M. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.08.067 · Cited by 14 · see citing works
Mathey, C. M., Maj, C., Scheer, A. B., Fazaal, J., Wedi, B., Wieczorek, D., Amann, P. M., Löffler, H., Koch, L., Schöffl, C., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.914376 · Cited by 13 · see citing works
Clinical experiences and case review of angiotensin II receptor blocker‐related angioedema in Korea
Kim, H., Baik, S. Y., Yang, S. J., Kim, T. M., Lee, S., Cho, J., Choi, I. Y., Kim, J. H., Yoon, K., & Kim, H. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13097 · Cited by 13 · see citing works
Messerli, F. H., Hofstetter, L., Agabiti‐Rosei, E., Burnier, M., Elliott, W. J., Franklin, S. S., Grodzicki, T. K., Kario, K., Kjeldsen, S. E., Kostis, J. B., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001435 · Cited by 13 · see citing works
Self-citationDouillard, M., Deheb, Z., Bozon, A., Raison‐Peyron, N., Dereure, O., Moulis, L., Soria, A., & Du-Thanh, A. (2023) · World Allergy Organization Journal · doi:10.1016/j.waojou.2023.100809 · Cited by 12 · see citing works
Hui, R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2517-9_6 · Cited by 12 · see citing works
Hereditary angioedema: a brief review of new developments
Altman, K., & Naimi, D. R. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.879441 · Cited by 12 · see citing works
Type 2 Diabetes and Chronic Kidney Disease: An Opportunity for Pharmacists to Improve Outcomes
Neumiller, J. J., Peter, W. L. S., & Shubrook, J. H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051367 · Cited by 10 · see citing works
Baicalin: a potential therapeutic agent for acute kidney injury and renal fibrosis
Li, X., Xu, R., Zhang, D., Ji, C., Zhou, H., Song, T., Wang, X., Kong, Q., Li, L., Liu, Z., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1511083 · Cited by 10 · see citing works
Considerations and controversies in managing chronic kidney disease: An update
Prasad‐Reddy, L., Isaacs, D. M., & Kantorovich, A. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160559 · Cited by 10 · see citing works
Contact System Activation and Bradykinin Generation in Angioedema
Christiansen, S. C., & Zuraw, B. L. (2024) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2024.03.011 · Cited by 9 · see citing works
Incidence and risk factors of angiotensin-converting enzyme inhibitor–induced angioedema
Garcia‐Saucedo, J. C., Trejo-Gutiérrez, J. F., Volcheck, G. W., Park, M. A., & Gonzalez‐Estrada, A. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.07.028 · Cited by 9 · see citing works
Lo, Y., & Tsai, T. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2045950 · Cited by 9 · see citing works
Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema
Wilkerson, R. G., & Winters, M. E. (2023) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2022.10.013 · Cited by 9 · see citing works
Savino, M. R., Mittal, P., & Miller, F. H. (2017) · Clinical Imaging · doi:10.1016/j.clinimag.2017.03.001 · Cited by 8 · see citing works
Postoperative angioedema induced by angiotensin-converting enzyme inhibitor: case report
Bisinotto, F. M. B., Seabra, B. C., Lóes, F. B. P., Martins, L. B., & da Silveira, L. A. M. (2019) · Brazilian Journal of Anesthesiology (English Edition) · doi:10.1016/j.bjane.2019.09.002 · Cited by 8 · see citing works
Fernandez‐Rando, M., Herrera, M. D., Almeida, C., & Grilo, A. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1786 · Cited by 8 · see citing works
Angioedema pós‐operatório induzido por inibidor da enzima conversora da angiotensina: relato de caso
Bisinotto, F. M. B., Seabra, B. C., Lóes, F. B. P., Martins, L. B., & da Silveira, L. A. M. (2019) · Brazilian Journal of Anesthesiology · doi:10.1016/j.bjan.2019.01.005 · Cited by 7 · see citing works
Toh, N., Ishii, K., Kihara, H., Iwakura, K., Watanabe, H., Yoshikawa, J., Ito, H., & for Effect of ARB/Diuretics on Diastolic Function in Patients with Hypertension 2 (EDEN2) trial investigators (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0815 · Cited by 7 · see citing works
Park, J., Kim, W.-J., Kim, W., Park, C., Choi, C. Y., Cho, J., Kim, S., & Cheong, H. (2021) · Journal of Medicinal Food · doi:10.1089/jmf.2020.4797 · Cited by 7 · see citing works
Expertise: No Longer a Sine Qua Non for Guideline Authors?
Messerli, F. H., Hofstetter, L., Agabiti‐Rosei, E., Burnier, M., Elliott, W. J., Franklin, S. S., Grodzicki, T. K., Kario, K., Kjeldsen, S. E., Kostis, J. B., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09470 · Cited by 7 · see citing works
Self-citationPapapostolou, N., Gregoriou, S., Katoulis, A., & Makris, M. P. (2024) · Pharmaceuticals · doi:10.3390/ph17030360 · Cited by 6 · see citing works
Looking beyond the angiotensin receptor blocker
Robertson, L.-M., & Clark, A. V. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.06.023 · Cited by 6 · see citing works
Schlienger, R. G., Korn, J. R., Wehler, E., López‐León, S., & Yeaw, J. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0242-3 · Cited by 6 · see citing works
- Authors
- Makani, H., Messerli, F. H., Romero, J., Wever-Pinzon, O., Korniyenko, A., Berrios, R. S., & Bangalore, S.
- Affiliations
- St. Luke's-Roosevelt Hospital Center (US)
- New York University (US)
- Corresponding author
- Messerli, Franz H.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 110
- Issue
- 3
- Pages
- 383-391
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2095519993
- Cited by
- 175
- References
- 65
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 7 · 2023: 12 · 2022: 10 · 2021: 14 · 2020: 13 · 2019: 11 · 2018: 13 · 2017: 14 · 2016: 13 · 2015: 14 · 2014: 16 · 2013: 17 · 2012: 3
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- angioedema, renin-angiotensin system inhibitors, ACE inhibitors, angiotensin receptor blockers, renin inhibitors, adverse drug reactions, heart failure, hypertension, coronary artery disease, drug safety comparison, placebo comparison
- MeSH terms
- Renin Inhibitors, Angioedema, Angiotensins, Female, Humans, Male, Middle Aged, Renin-Angiotensin System, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
